ADMA Biologics, Inc.ADMANASDAQ
Loading
Debt to Equity Over TimeCompressed
Percentile Rank14
3Y CAGR-45.2%
5Y CAGR-31.5%
Year-over-Year Change
Debt-to-equity ratio
3Y CAGR
-45.2%/yr
vs -17.9%/yr prior
5Y CAGR
-31.5%/yr
Recent deceleration
Acceleration
-27.3pp
Decelerating
Percentile
P14
Within normal range
vs 5Y Ago
0.2x
Contraction
Streak
2 yr
Consecutive declineCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.17 | -28.9% |
| 2024 | 0.24 | -77.5% |
| 2023 | 1.05 | +2.9% |
| 2022 | 1.02 | +39.4% |
| 2021 | 0.73 | -34.1% |
| 2020 | 1.11 | -65.8% |
| 2019 | 3.23 | +44.6% |
| 2018 | 2.24 | +110.0% |
| 2017 | 1.07 | +123.4% |
| 2016 | -4.55 | - |